Both copyright and copyright belong to a group of drugs called GLP-1 receptor agonists . These innovative substances function by mimicking the body's inherent hormone , Glucagon-like Peptide-1, to assist reduce glucose levels and stimulate weight loss . This shared mechanism of action explains why these therapies are commonly evaluated together and